Utah Medical Products, Inc. (UTMD) key performance indicators and operating metrics (8 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Gross Profit Margin | 60.60 percent | FY2026-Q1 |
| Operating Income Margin | 29.40 percent | FY2026-Q1 |
| Domestic Sales | 5.56M | FY2026-Q1 |
| International Sales Outside the United States | 3.16M | FY2026-Q1 |
| Net Income Margin (Non-US GAAP, Before Deferred Tax Liability Adjustment) | 29.90 percent | FY2026-Q1 |
| Income Before Tax Margin | 36.50 percent | FY2026-Q1 |
| Adjusted Consolidated Earnings Before Interest, Taxes, Depreciation, and Amortization Margin | 43.80 percent | FY2025-Q4 |
| Adjusted Consolidated Earnings Before Interest, Taxes, Depreciation, and Amortization | 4.17M | FY2025-Q3 |
Back to UTMD overview · UTMD earnings · UTMD holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.